DIAREX

This brand name is authorized in Ecuador.

Active ingredients

The drug DIAREX contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Nifuroxazide UNII `PM5LI0P38J` - NIFUROXAZIDE
	Nifuroxazide is a member of benzoic acids. Nifuroxazide is often used as an anti-diarrhoeal medicine.
	Read more about Nifuroxazide
`2`	Attapulgite UNII `U6V729APAM` - ATTAPULGITE
	Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. It physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications.
	Read more about Attapulgite

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07BC54	Attapulgite, combinations	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07B Intestinal adsorbents → A07BC Other intestinal adsorbents
Discover more medicines within A07BC54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	04473-MAN-11-06, 5848-MAN-08-10

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.